Equitec Specialists’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,137
Closed -$127K 250
2020
Q3
$127K Sell
1,137
-4,529
-80% -$508K 0.01% 108
2020
Q2
$593K Buy
+5,666
New +$607K 0.09% 77

Other funds holding BSX.PRA

Equitec Specialists's BSX.PRA Position: Q4 2020 in Review

Equitec Specialists sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2020, closing a stake of 1,137 shares — an estimated $127K sold.

Equitec Specialists first reported a position in BSX.PRA in Q2 2020 and held it in 2 quarters. The position peaked at $593K in Q2 2020. 7 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2020.

  • Equitec Specialists reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2020 after selling out during the quarter.
  • Equitec Specialists sold 1,137 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2020, an estimated $127K.
  • Equitec Specialists first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 2 quarters.
  • Equitec Specialists's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $593K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2020.

Based on Equitec Specialists's 13F filing for Q4 2020, filed 26 Jan 2021.